Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide vs placebo in pediatric relapsing multiple sclerosis (China)
CTR20160264Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started May 2016; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20160264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160264.